Skip to main content

Table 1 Patient characteristics

From: In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer

  N
Number of patients 32
Age -- (y)  
   Median 60
   Range 34-78
Histological type  
   serous/serous-papillary 31
   Endometrioid 1
Histological grade  
   G 2 12
   G 3 20
Stage  
   III C 30
   IV 2
CA 125 (U/mL)  
   Median 1376
   Range (86-9030)
CA 125 (U/mL) after preoperative treatment  
   Median 71
   Range (17-2794)
Number of chemotherapy cylcles before cytoreductive surgery  
   Two 19
   Three 13
Residual disease after cytoreductive surgery  
   no gross residual disease 9
   ≤ 1 cm 19
   >1 cm 4
Lymph node status  
   N0* 13
   N1 7
   NX 12
Recurrence status (%)  
   recurrent disease 21
   Dead 17
  1. *at least 25 lymph nodes